Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,380,000
New position
Shares Held
500,000
first reported quarter
Ownership
0.216%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Southpoint Capital Advisors LP holds $270,442,000 across 2 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,200,000 | $260,062,000 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
This page
|
500,000 | $10,380,000 |
All Filings in HIMS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,380,000 | 500,000 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||